Company Search:
Advanced Search
Sponsored Links
Cormedix Incorporation Company Snapshot
Cormedix Incorporation operates in the Commercial physical research sector. In addition to historical fundamental analyses, the complete report available to purchase compares Cormedix Incorporation with three other companies in this sector in the United States: Dicerna Pharmaceuticals Inc (2015 sales of $184,000.00 of which 100% was RNA Interference (RNAi) Therapeutics), Nantkwest Inc ($236,000.00 of which 100% was Pharmaceutical), and Matinas BioPharma Holdings Inc ($194,494.00 ).

Sales Analysis.
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Cormedix Incorporation
  Stock Performance Chart for Cormedix Incorporation
  Stock Data: Recent Stock Performance:
  Current Price (2/17/2017): 2.27
(Figures in U.S. Dollars)
1 Week -5.4%   13 Weeks 40.1%  
4 Weeks 23.4%   52 Weeks 19.5%  
Cormedix Incorporation Key Data:
  Ticker: CRMD Country: United States
  Exchanges: ASE Major Industry: Commercial Services & Supplies
    Sub Industry: Commercial Physical Research
  2015 Sales 210,130
(Year Ending Jan 2016).
Employees: 9
  Currency: U.S. Dollars Market Cap: 91,766,428
  Fiscal Yr Ends: December Shares Outstanding: 40,425,739
  Share Type: Common Closely Held Shares: 823,079
Sponsored Links
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.